Anika Therapeutics
ANIK
ANIK
119 hedge funds and large institutions have $341M invested in Anika Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
29% less capital invested
Capital invested by funds: $483M → $341M (-$142M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Holders
119
Holding in Top 10
–
Calls
$213K
Puts
$264K
Top Buyers
| 1 | +$9.11M | |
| 2 | +$6.74M | |
| 3 | +$3.29M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$2.83M |
| 5 |
Goldman Sachs
New York
|
+$2.26M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$1.44M | |
| 3 | -$1.37M | |
| 4 |
Millennium Management
New York
|
-$1.09M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.07M |